These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 12240852
1. Hepatorenal syndrome: pathophysiology and treatment. Pandey CK, Singh N, Kumar V, Agarwal A, Baronia AK, Gaur A, Singh PK, Singh S. J Assoc Physicians India; 2002 Jun; 50():819-25. PubMed ID: 12240852 [Abstract] [Full Text] [Related]
2. Pathophysiology, clinical features and management of hepatorenal syndrome. Garzia P, Ferri GM, Ilardi M, Messina FR, Amoroso A. Eur Rev Med Pharmacol Sci; 1998 Jun; 2(5-6):181-4. PubMed ID: 10710816 [Abstract] [Full Text] [Related]
3. [Hepatorenal syndrome]. Mijac D, Kezić A, Stojimirović B. Srp Arh Celok Lek; 2007 Jun; 135(1-2):98-104. PubMed ID: 17503577 [Abstract] [Full Text] [Related]
4. Hepatorenal syndrome: new perspectives in pathophysiology and management. Kes P. Acta Med Croatica; 2000 Jun; 54(4-5):165-73. PubMed ID: 11379481 [Abstract] [Full Text] [Related]
5. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U. Hepatogastroenterology; 2003 Jun; 50(54):1753-5. PubMed ID: 14696397 [Abstract] [Full Text] [Related]
6. Pathophysiology and treatment of hepatorenal syndrome. Wong F, Blendis L. Gastroenterologist; 1998 Jun; 6(2):122-35. PubMed ID: 9660529 [Abstract] [Full Text] [Related]
13. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention? Møller S, Henriksen JH. Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398 [Abstract] [Full Text] [Related]
14. Diagnosis and treatment of hepatorenal syndrome. Ginès P. Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):945-57. PubMed ID: 11139348 [Abstract] [Full Text] [Related]
15. [Hepatorenal syndrome in patients with liver cirrhosis]. Zaza S, Bonny O, Liaudet L. Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684 [Abstract] [Full Text] [Related]
16. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Wong F, Pantea L, Sniderman K. Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086 [Abstract] [Full Text] [Related]
17. [Hepatorenal syndrome: pathogenesis and treatment]. Ashkenazi E, Ilan Y, Shoval D. Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404 [Abstract] [Full Text] [Related]
18. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy. Arroyo V. Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402 [Abstract] [Full Text] [Related]
19. New challenge of hepatorenal syndrome: prevention and treatment. Wong F, Blendis L. Hepatology; 2001 Dec; 34(6):1242-51. PubMed ID: 11732014 [Abstract] [Full Text] [Related]
20. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, Rodés J, Ginès P. Hepatology; 2005 Jun; 41(6):1282-9. PubMed ID: 15834937 [Abstract] [Full Text] [Related] Page: [Next] [New Search]